Saturday, May 5, 8:00 a.m. – 1:30 p.m.
McNamara Alumni Center
200 Oak Street SE, Minneapolis, MN
The 13th Annual Cancer Survivorship Conference, a collaboration between University of Minnesota Physicians and University of Minnesota Medical Center, is an excellent opportunity for survivors, parents, and caregivers, as well as healthcare professionals, to explore issues survivors face after cancer treatment. The free conference will “focus on maintaining wellness, while exploring the issues survivors and their families often face after cancer treatment or following blood and marrow transplantation. Survivors and their support system will learn how to better advocate for themselves and lead full and productive lives.”Read More
Is your 2018 calendar filling up? Please add these upcoming Rein in Sarcoma events now, so that you'll be able to attend one —or all of our events and help us continue our threefold mission of patient support, education and research. Our events are great ways to connect with the sarcoma community and get involved with the Rein in Sarcoma family. We look forward to exciting opportunities to change the sarcoma story with you!
Monday, July 23
Como Park, St. Paul, MN
Dedicated to finding a cure for sarcoma cancers, our signature event, Party in the Park, is a joyous celebration. Hundreds of sarcoma patients, survivors and their loved ones gather for the Sarcoma Family Picnic, which is followed by the Party in the Park - an evening of music, entertainment, inspiration and fun for all ages.
Monday, August 20
Historical Keller Golf Course, Maplewood, MN
Clean up your clubs and get ready for a day of great golf and fellowship to benefit the Rein in Sarcoma mission. Lunch, dinner, range balls, golf and cart are included with registration for the Second Annual RIS Charity Golf Challenge. Prizes for winners. Register a group of four golfers or as an individual player.
Thursday, October 11
Nicollet Island Pavilion, Minneapolis, MN
Our annual Fall Fundraiser brings together members of the medical community, sarcoma survivors, and friends and family with generous hearts to change the sarcoma story. Join us for an evening of great entertainment, fine dining and inspirational speakers.
We’d like to draw your attention to a promising new therapy for osteosarcoma patients that recently went to clinical trial at the Masonic Cancer Center and at 30 other hospitals around the country. This is exciting news for a disease which has had little in the way of new treatments in the past 30 years.
Masonic Cancer Center of the University of Minnesota researchers, led by Dr. Brandon Moriarity, developed this therapy which uses an antibody, VX15, developed by Vaccinex, to block the activity if semaphorin 4D (SEMA4D), a causative gene of osteosarcoma. The VX15 activates the immune system and can cause the immune system to kill the osteosarcoma cancer cells.
1. Divine, M (2018), ‘A new cancer treatment is in clinical trial thanks to Zach Sobiech fund’, TwinCitiesPioneesPress.com, 10 February, accessed March 5, 2018.